Research suggests that regular coffee consumption is consistently associated with improved markers of liver health, including lower liver enzyme levels, reduced rates of fatty liver disease, fibrosis, cirrhosis, and liver cancer, particularly among individuals already at risk for liver conditions. The evidence base draws primarily from multiple review articles and observational studies spanning a range of liver conditions — including nonalcoholic fatty liver disease, hepatitis B and C, and alcoholic liver disease — with proposed biological mechanisms involving antioxidant activity, reductions in fat and collagen accumulation, anti-inflammatory effects, and even epigenetic changes in gene expression related to fat metabolism. One small short-term randomized controlled trial examined a multi-ingredient supplement containing green coffee bean extract alongside other compounds and found favorable changes in liver enzyme markers, though the mixed formulation makes it difficult to isolate coffee's specific contribution. While the overall direction of the literature is supportive, most findings come from observational and review-level research rather than controlled trials, meaning causation has not been firmly established, and researchers consistently note that coffee's role is best understood as a potential complement to standard care rather than a standalone intervention.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Coffee and liver health. | Review | 2014 | Supports | 100 |
| Coffee and Liver Disease. | Review | 2016 | Supports | 95 |
| Coffee and tea breaks for liver health. | Other | 2017 | — | 90 |
| Pharmacokinetics of caffeine: A systematic analysis of reported data for appl... | Other | 2021 | Supports | 85 |
| Antioxidants in liver health. | Review | 2015 | Mixed | 85 |
| Epigenome-wide association meta-analysis of DNA methylation with coffee and t... | Other | 2020 | Supports | 80 |
| Coffee and nonalcoholic fatty liver disease: A review. | Other | 2020 | Supports | 80 |
| Bacterial pathogen deploys iminosugar galactosyrin to manipulate plant glycob... | Other | 2025 | Neutral | 75 |
| Novel Multi-Ingredient Supplement Facilitates Weight Loss and Improves Body C... | RCT | 2023 | Mixed | 75 |
| Exploring the impact of coffee consumption on liver health: A comprehensive b... | Review | 2024 | Supports | 70 |
| Correction for participation bias in the UK Biobank reveals non-negligible im... | Other | 2022 | Neutral | 70 |
| <i>In vitro</i>efficacy of Artemisinin-based treatments against SARS-CoV-2 | Other | 2020 | Neutral | 65 |
| Potential Mechanisms Underlying the Role of Coffee in Liver Health. | Review | 2018 | Supports | 65 |
| Coffee and liver health: Exploring the protective benefits and mechanisms of ... | Other | 2025 | — | 60 |
| Nfe2l1-mediated proteasome function controls muscle energy metabolism in obesity | Other | 2023 | Neutral | 60 |
| Investigating the relationship between liver health status with coffee and te... | Other | 2024 | Mixed | 55 |
| Systematic <i>in silico</i> discovery of novel solute carrier-like proteins f... | Other | 2021 | Neutral | 55 |
| Coffee for the liver: a mechanistic approach. | Review | 2025 | Supports | 50 |
| Structural analysis of SARS-CoV-2 genome and predictions of the human interac... | Other | 2020 | Neutral | 50 |
| Behavioral and psychological aspects of coffee consumption. | Review | 2024 | Supports | 45 |
| Alcohol, tobacco and coffee consumption and liver disease severity among indi... | Other | 2020 | Neutral | 40 |
| Corrigendum to "Coffee and tea breaks for liver health" [J Hepatol 67 (2017) ... | Other | 2017 | — | 35 |
| Coffee and Tea Intake Is Inversely Associated With Hepatic Fat Deposition, Ir... | Other | 2025 | Supports | 30 |